Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
Saved in:
| Title: | Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. |
|---|---|
| Authors: | Reustle, Anna1,2 (AUTHOR), Di Marco, Moreno3 (AUTHOR), Meyerhoff, Carolin1,2 (AUTHOR), Nelde, Annika3,4,5 (AUTHOR), Walz, Juliane S.4,5,6 (AUTHOR), Winter, Stefan1,2 (AUTHOR), Kandabarau, Siahei1,2 (AUTHOR), Büttner, Florian1,2 (AUTHOR), Haag, Mathias1,2 (AUTHOR), Backert, Linus3 (AUTHOR), Kowalewski, Daniel J.3 (AUTHOR), Rausch, Steffen7 (AUTHOR), Hennenlotter, Jörg7 (AUTHOR), Stühler, Viktoria7 (AUTHOR), Scharpf, Marcus8 (AUTHOR), Fend, Falko8 (AUTHOR), Stenzl, Arnulf7 (AUTHOR), Rammensee, Hans-Georg3,5,6 (AUTHOR), Bedke, Jens7 (AUTHOR), Stevanović, Stefan3,5,6 (AUTHOR) |
| Source: | Genome Medicine. 3/30/2020, Vol. 12 Issue 1, p1-24. 24p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1756994X |
|---|---|
| DOI: | 10.1186/s13073-020-00731-8 |